Stay updated on Tau Vaccine Safety in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page.

Latest updates to the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record for the tau-targeted Alzheimer’s vaccine study is available, including its eligibility criteria, study design, outcome measures, and posted results. It also provides study documents and information about data sharing.SummaryDifference71%

- Check12 days agoChange DetectedThe site revision label in the footer changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide notice was added announcing an NIH website transition and stating that some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record content and navigation with an access-block screen, indicating the record is temporarily unavailable.SummaryDifference21%

Stay in the know with updates to Tau Vaccine Safety in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page.